home / stock / gtbp / gtbp short
Short Information | GT Biopharma Inc. (OTCMKTS:GTBP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,991,368 |
Total Actual Volume | 8,343,388 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 8 |
No Change Days | 9 |
Averages | |
---|---|
Average Short Volume | 199,568 |
Average Short Percentage | 46.65% |
Is there a GTBP Short Squeeze or Breakout about to happen?
See the GTBP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-10-2021 | $0.43 | $0.5 | $0.5 | $0.42 | 788,756 | 510,635 | 64.74% |
02-09-2021 | $0.41 | $0.44 | $0.45 | $0.41 | 552,771 | 351,489 | 63.59% |
02-08-2021 | $0.435 | $0.4249 | $0.445 | $0.4 | 395,468 | 170,346 | 43.07% |
02-05-2021 | $0.43505 | $0.445 | $0.45 | $0.43 | 253,850 | 132,029 | 52.01% |
02-04-2021 | $0.375 | $0.44 | $0.45 | $0.375 | 249,591 | 111,348 | 44.61% |
02-03-2021 | $0.31 | $0.447 | $0.48 | $0.31 | 279,836 | 168,289 | 60.14% |
02-02-2021 | $0.455 | $0.42 | $0.455 | $0.3707 | 526,408 | 152,812 | 29.03% |
02-01-2021 | $0.48 | $0.4326 | $0.482 | $0.42 | 355,627 | 110,994 | 31.21% |
01-29-2021 | $0.44 | $0.47 | $0.485 | $0.44 | 297,404 | 93,635 | 31.48% |
01-28-2021 | $0.45 | $0.4626 | $0.48 | $0.4444 | 512,729 | 223,707 | 43.63% |
01-27-2021 | $0.485 | $0.46 | $0.485 | $0.45 | 572,499 | 310,201 | 54.18% |
01-26-2021 | $0.46 | $0.46 | $0.48 | $0.45 | 257,522 | 106,189 | 41.23% |
01-25-2021 | $0.44 | $0.46 | $0.5 | $0.44 | 475,553 | 250,085 | 52.59% |
01-22-2021 | $0.42 | $0.44 | $0.46 | $0.42 | 202,517 | 85,771 | 42.35% |
01-21-2021 | $0.4399 | $0.44 | $0.4494 | $0.4 | 316,731 | 162,781 | 51.39% |
01-20-2021 | $0.42 | $0.4399 | $0.4495 | $0.36 | 582,290 | 240,208 | 41.25% |
01-19-2021 | $0.46 | $0.415 | $0.5 | $0.41 | 794,959 | 370,622 | 46.62% |
01-15-2021 | $0.52 | $0.485 | $0.52 | $0.47 | 366,036 | 196,794 | 53.76% |
01-14-2021 | $0.52 | $0.5099 | $0.52 | $0.47 | 316,637 | 140,925 | 44.51% |
01-13-2021 | $0.4521 | $0.52 | $0.5289 | $0.4521 | 246,204 | 102,508 | 41.64% |
News, Short Squeeze, Breakout and More Instantly...
GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025 GTB-5550 TriKE ® IND submission for treatment of B7H3 positive solid tumors expected in Q1 2025 GTB-5550 Phase 1 dose escalation basket trial initiation expected in 20...
BRISBANE, CALIFORNIA, May 21, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), today announced that it has entered into a definitive securities purchase agreements for the purchase and sale of 740,000 shares of the Company’s common stock at a purcha...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 16.4% to $0.199 on volume of 720,586,242 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 74.8% to $1.8 on volume of 682,362,254 shares Pineapple Energy Inc. (PEGY) rose 80.3% to $0.1...